NIH-funded research U01 cooperative agreement

Improving cancer risk identification for patients with inherited cancer syndromes.

Official title: Improving identification and healthcare for patients with Inherited Cancer Syndromes: Evidence-based EMR implementation using a web-based computer platform

Funded at Vanderbilt University Medical Center · NIH-10831647 · Data updated 2026-11-12

This study is working to help people, especially those in marginalized communities like transgender and gender diverse individuals, better understand their risk for hereditary cancers by using a user-friendly online tool called MeTree to gather important health information, so they can get the right care and support for early detection and prevention.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$100,000
NIH project number3U01CA232829-01A1S1
Project IDNIH-10831647 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include transgender, gender diverse, and sex diverse individuals who may be at risk for hereditary cancers.

Less likely to help

Patients who do not identify as transgender or gender diverse may not receive direct benefits from this research.

What this research studies

This research focuses on enhancing the identification and healthcare of individuals at risk for hereditary cancers, particularly within marginalized communities such as transgender and gender diverse patients. It aims to implement a web-based platform that systematically collects and analyzes risk-related data to improve cancer risk assessments. By utilizing an electronic app called MeTree, the project seeks to ensure accurate and culturally competent data collection, which is crucial for providing appropriate care and interventions. The approach emphasizes early detection and prevention of cancer through better screening practices.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer risk assessments and earlier interventions for patients with inherited cancer syndromes.

How similar studies have gone: Previous research has shown success in using electronic platforms for health assessments, indicating potential for this approach to effectively address health disparities.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Wiesner, Georgia L — Vanderbilt University Medical Center
  • Study coordinator: Wiesner, Georgia L

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.